Literature DB >> 33685194

SNHG7 and FAIM2 are up-regulated and co-expressed in colorectal adenocarcinoma tissues.

Farinaz Ziaee, Mohammadreza Hajjari, Reza Seyed Kazeminezhad, Mehrdad Behmanesh.   

Abstract

BACKGROUND: The global incidence of colorectal cancer (CRC) is expected to be increased by 60% until a few years. Despite the advances in surgical and chemotherapy techniques, a significant proportion of patients with CRC have poor responses to treatments. These are the reasons that prove the importance of identifying molecular bio-markers as potential therapeutic targets. Long non-coding RNAs (lnc RNAs) participate in the initiation, development, progression, and metastasis of cancers such as CRC. Hence, this class of noncoding RNAs is known as bio-marker for cancer dia-gnosis and prognosis.
MATERIALS AND METHODS: In this experimental study, the extraction of total RNA from tissues, synthesis of complementary DNA as well as quantitative real-time polymerase chain reaction (qRT- PCR) were performed. Comparative cycle threshold method was applied to quantify the expression level of lncRNA-SNHG7 and FAIM2. The relative amount of lncRNA-SNHG7 and FAIM2 was calculated using the equation 2 -DDCT.
RESULTS: In this study, by qRT PCR, we concluded that the expression level of SNHG7, as a recently identified lncRNA and FAIM2 were increased in colorectal cancer tissues compared with normal adjacent tissues.
CONCLUSION: Our study indicates the potential importance of SNHG7 and FAIM2 expression for more studies in future.

Entities:  

Keywords:  lncRNA-SNHG7 – FAIM2 – colorectal cancer

Year:  2020        PMID: 33685194

Source DB:  PubMed          Journal:  Klin Onkol        ISSN: 0862-495X


  2 in total

1.  Long Noncoding RNA SNHG7 Is a Diagnostic and Prognostic Marker for Colon Adenocarcinoma.

Authors:  Chengwei Jiang; Shanshan Qu; Tie Liu; Miao Hao
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

2.  FAIM2 Promotes Non-Small Cell Lung Cancer Cell Growth and Bone Metastasis by Activating the Wnt/β-Catenin Pathway.

Authors:  Kelin She; Wensheng Yang; Mengna Li; Wei Xiong; Ming Zhou
Journal:  Front Oncol       Date:  2021-09-09       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.